Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. 

Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system.

In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc.

Visit us at www.abbottvascular.com for current information about the company.

Biotechnology

Health Care

Medical Devices

Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.]

Ferolyn Powell

Jan Komtebedde

Gloria Valencia

John Rasmusson

Meera Kottar

Tin Hoang

Misty Earley

The Leadership Team at Evalve, Inc. is responsible for setting the strategic direction of the company, driving innovation in cardiac valve repair technologies, and ensuring operational excellence. Comprising key executives, including the CEO and VP of Valve Therapy, this team collaborates to oversee product development, regulatory compliance, and financial management, ultimately aiming to enhance patient outcomes and expand market presence for the MitraClip® system and other solutions.

Leadership Team

Manufacturing and Quality Assurance

Leadership Team

About

Team members

Other teams at Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.]

Manufacturing and Quality Assurance